Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Meineke

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or inductionC De Mey, I Meineke, V W Steinijans, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or inductionC De Mey, I Meineke, V W Steinijans, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranesS V Löser, J Meyer, S Freudenthaler, et al.
Clinical Pharmacology and Therapeutics|April 17, 2009
Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteersS V Vormfelde, J Brockmöller, S Bauer, et al.
Clinical Pharmacology and Therapeutics|April 27, 2007
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugsS V Vormfelde, D Sehrt, M R Toliat, et al.
Clinical Pharmacology and Therapeutics|June 19, 2009
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metforminM V Tzvetkov, S V Vormfelde, D Balen, et al.
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 6, 2005
Region specific distribution of levomepromazine in the human brainJ Kornhuber, H Weigmann, J Röhrich, et al.
The American Journal of Psychiatry|June 9, 1999
Persistence of haloperidol in human brain tissueJ Kornhuber, A Schultz, J Wiltfang, et al.
Clinical Pharmacology and Therapeutics|October 5, 2007
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effectsA Kühne, O Sezer, U Heider, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or inductionC De Mey, I Meineke, V W Steinijans, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 1, 1994
Pantoprazole lacks interaction with antipyrine in man, either by inhibition or inductionC De Mey, I Meineke, V W Steinijans, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1996
Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranesS V Löser, J Meyer, S Freudenthaler, et al.
Clinical Pharmacology and Therapeutics|April 17, 2009
Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteersS V Vormfelde, J Brockmöller, S Bauer, et al.
Clinical Pharmacology and Therapeutics|April 27, 2007
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugsS V Vormfelde, D Sehrt, M R Toliat, et al.
Clinical Pharmacology and Therapeutics|June 19, 2009
The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metforminM V Tzvetkov, S V Vormfelde, D Balen, et al.
Clinical Pharmacology and Therapeutics|November 14, 2008
Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9C Sachse-Seeboth, J Pfeil, D Sehrt, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 6, 2005
Region specific distribution of levomepromazine in the human brainJ Kornhuber, H Weigmann, J Röhrich, et al.
The American Journal of Psychiatry|June 9, 1999
Persistence of haloperidol in human brain tissueJ Kornhuber, A Schultz, J Wiltfang, et al.
Clinical Pharmacology and Therapeutics|October 5, 2007
Population pharmacokinetics of melphalan and glutathione S-transferase polymorphisms in relation to side effectsA Kühne, O Sezer, U Heider, et al.
Pageof 6